WaveSense develops, manufactures, and markets award winning breakthrough analytical nanotechnologies for use in cellular and molecular assay markets. Some applications we actively engage in consist of drug discovery, companion diagnostic development, veterinary diagnostics, and rare cell detection in blood, urine, and bone marrow.
Our Quality Policy:
WaveSense is committed to providing safe and effective products to the life science diagnostics community as it endeavors to improve standard of care and patient outcomes.
To achieve this on an ongoing basis:
- We are dedicated to continuously improving the effectiveness of our Quality Management System.
- We manufacture our products in accordance with FDA Quality System Regulations.
- We provide leading edge technology and tools that support best medical practices.
- We seek feedback and listen to our customers.
Our Proprietary Technology:
Our patented technology, branded as EpiSep®, is a magnetically based lateral flow separations platform that provides rapid enrichment of live cells, proteins, and/or genes for advanced detection and characterization. Researchers and clinicians can then harvest the targets for interrogation purposes within their desired application.
Our Value Proposition:
WaveSense products are designed to overcome specimen preparation challenges encountered with existing platforms that do not meet the requirements of current assays detecting rare targets. Our EpiSep® platforms, and extensive line of leading-edge assays, are revolutionary to the analytical industry and fulfill a critical demand to significantly improve test sensitivity and workflow while reducing operational costs and complexity.
Users of Our Products:
End users of our products consist of reference laboratories, pathologists, and researchers that perform a wide variety of analytical tests for diagnostic and research purposes.
Why We Do This:
We strive to improve the quality and length of life by discovering and applying leading-edge nanotechnologies to life science research. We adopt this approach with an added interest to create value for our employees and shareholders.
WaveSense is a privately held company founded in 1999 by Christopher Feistel and Robert Coleman. Individually and collectively, Feistel and Coleman have participated as principal inventor, co-founder, chairman, president and/or CEO of more than 10 medical device companies resulting in successful organizations with combined valuations exceeding one billion dollars.
Our corporate offices and laboratory are housed in an 8500 Square Foot facility located at 15339 Barranca Parkway, Irvine, CA 92618.